Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 203
APPENDIX A
Workshop Agenda
IMPROVING THE TRANSLATION OF RESEARCH FINDINGS
INTO CLINICAL PRACTICE: WORKSHOP IV
Examining Coverage and Adoption Decisions
About Medical Technologies
Friday, September 18, 1992
8:30 a.m. Registration and Continental Breakfast
9:00 Welcome and Opening Remarks
Kenneth Shine, President, Institute of Medicine
SESSION I. SETTING THE STAGE
Moderator: Gerald Laubach, Chair, Committee on Technological
Innovation in Medicine
9:15
9:45 Discussion
The Nature of Technological Change: Incentives Matter!
Burton Weisbrod, Northwestern University
SESSION II. PROVIDER DECISIONMAKING
Moderator: Richard Nesson, Brigham and Women's Hospital
10:00
An Overview of Coverage and Adoption Decisionmaking by
Payers and Providers
Bryan Luce and Ruth Brown, Battelle
203
OCR for page 204
204
10:30
11:00
1 1:15
1 1:45 Discussion
12:30 Lunch
WORKSHOP AGENDA
Role of the Hospital in the Acquisition of Technology
Gerard Anderson and Earl Steinberg, Johns Hopkins University
Break
Physicians' Decisions Regarding the Acquisition of Technology
Mark Fendrick and Sanford Schwartz, University of Pennsylvania
SESSION III. THIRD PARTY PAYER COVERAGE DECISIONS
Moderator: Michael Soper, CIGNA
The Experience of Blue Cross and Blue Shield Association
Susan Gleeson, Blue Cross and Blue Shield Association
Decisionmaking at the Health Care Financing Administration
Kathleen Buto, Health Care Financing Administration
2:45
3:15
Current and Future Approaches to Coverage in a Group-
Model Health Maintenance Organization
Paul Lairson, Kaiser Permanente
Break
High Dose Chemotherapy-Autologous Bone Marrow Trans-
plantation: A Model for Health Care Decisionmaking?
William McGivney, Aetna Health Plans
4:00 Legal Implications of Experimental Exclusions
Lee Newcomer, United HealthCare
4:30
6:00
Discussion
Adjournment and Reception
Reception Speech: Fishbowl Medicine Versus
Muddling Through
Uwe Reinhardt, Princeton University
OCR for page 205
WORKSHOP AGENDA
Saturday, September 19, 1992
8:00 a.m. Continental Breakfast
SESSION IV. INCREASING THE RATIONALITY OF COVERAGE
DECISIONMAKING
Moderator: Uwe Reinhardt, Princeton University
9:15
9:45
10:15
10:30
11:00
11:30
12:00
12:30
205
Strengthening the Connection Between Evaluative Research
and Coverage Decisionmaking
Lucian Leape, Harvard School of Public Health
Manufacturers' Responses to the Increased Demand for
Outcomes Research
Ann Marshall, Abbott Laboratories
Discussion
Break
Paying for Evaluative Research
Alan Garber, Palo Alto Veterans Administration Medical Center
and Stanford University
Health Care Reform: Implications for Decisionmaking
Susan Bartlett Foote, Staff, U.S. Senate
Panel Discussion:
Lucian Leape, Harvard School of Public Health
Ann Marshall, Abbott Laboratories
Alan Garber, Stanford University
Susan Bartlett Foote, Staff, U.S. Senate
Discussion
Summary of the Conference and Adjournment
Uwe Reinhardt, Princeton University
Representative terms from entire chapter:
bartlett foote
